ENTITY

Merus NV (MRUS US)

8
Analysis
Health Care • Netherlands
Merus N.V. operates as a clinical-stage immuno-oncology company. The Company focuses on developing bispecific antibody therapeutics. Merus develops and manufactures therapeutics to treat and cure cancer patients.
more
Exchange Announcement • 30 Dec 2025 21:32

Current Report (Form 8-K | Period ending 2025-12-29)

Exchange Announcement • 12 Dec 2025 20:54

Current Report (Form 8-K | Period ending 2025-12-12)

Exchange Announcement • 10 Dec 2025 05:00

Current Report (Form 8-K | Period ending 2025-12-09)

Exchange Announcement • 12 Nov 2025 21:00

DEFM14A | Definitive proxy statement relating to merger or acquisition

Exchange Announcement • 01 Nov 2025 04:00

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

x